Ergomed appoints former Acergy SA bigwig Steve Jackson as CFO
Pharmaceutical services firm Ergomed on Monday appointed 58 year old veteran executive Stuart Jackson as chief financial officer with immediate effect.
Ergomed
1,346.00p
08:02 13/11/23
FTSE AIM All-Share
755.28
17:14 26/04/24
Pharmaceuticals & Biotechnology
22,773.26
16:59 26/04/24
The AIM-traded company said Jackson has over two decades of experience at chief financial officer level, having held the position at a variety of companies listed on the London, NASDAQ and Oslo stock exchanges, with particular experience in the energy, technology and telecommunications sectors.
Stephen Stamp, chief executive of Ergomed, said: "Stuart brings to Ergomed a strong track record of delivery within project and service related businesses on an international scale. His experience in non-healthcare services businesses will provide a broader perspective to our project delivery and he will play an integral role in enhancing the strong foundations of Ergomed."
As chief financial officer at Acergy SA, Jackson was responsible for the financial restructuring of the business and implementation of the new business strategy which took Acergy from $0.1bn to $6.0bn market capitalization in four years.
Other companies at which he has served in the role include CEONA, a Goldman Sachs Capital Partners group of companies, and Bibby Offshore Holdings Limited.
Peter George, chairman of Ergomed, said: "I am very pleased to welcome Stuart to the Ergomed plc board. His expertise and experience across a broad range of businesses will be invaluable as we continue to grow our services and expand into new related areas."
Jackson currently holds three other directorships and has held 20 others in the past five years.
1149 BST, Ergomed’s shares were up 3.89% at 187.00p.